Frost-Pineda K et al. |
Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. |
2011 |
Nicotine Tob. Res. |
pmid:21330277
|
Varma D et al. |
Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". |
2011 |
Bioanalysis |
pmid:21510759
|
Shen L et al. |
In vivo oxidation, platelet activation and simultaneous occurrence of natural immunity in atherosclerosis-prone mice. |
2011 |
Isr. Med. Assoc. J. |
pmid:21845968
|
Lessiani G et al. |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. |
2011 |
Thromb. Haemost. |
pmid:21103664
|
Lynch CM et al. |
The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21723954
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Halawani SH et al. |
Aspirin failure in patients presenting with acute cerebrovascular ischaemia. |
2011 |
Thromb. Haemost. |
pmid:21544317
|
Gonçalves LH et al. |
Urinary 11-dehydro thromboxane Bâ‚‚ levels in type 2 diabetic patients before and during aspirin intake. |
2011 |
Clin. Chim. Acta |
pmid:21510926
|
Simeoni S et al. |
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. |
2011 |
Stress |
pmid:21434833
|
Gremmel T et al. |
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. |
2011 |
Platelets |
pmid:21231857
|
Dragani A et al. |
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. |
2010 |
Blood |
pmid:19887674
|
Alusik S et al. |
The inhibitory effect of statins on urinary 11-dehydrothromboxane levels. |
2010 |
Int Angiol |
pmid:20502413
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Montine TJ et al. |
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. |
2010 |
PLoS ONE |
pmid:20174466
|
Zisman E et al. |
Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. |
2010 |
Eur J Anaesthesiol |
pmid:20035230
|
Boizel R et al. |
Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes. |
2010 |
Diabetologia |
pmid:20535444
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Fukushima H et al. |
Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. |
2010 |
Am. J. Med. Genet. A |
pmid:20583254
|
Ferrante E et al. |
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. |
2010 |
Free Radic. Biol. Med. |
pmid:20541603
|
Santilli F et al. |
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. |
2010 |
J. Thromb. Haemost. |
pmid:20088941
|